Where Does Wall Street Think Satsuma Pharmaceuticals Inc (STSA) Stock Will Go?

Tuesday, April 25, 2023 10:18 AM | InvestorsObserver Analysts

Mentioned in this article

Where Does Wall Street Think Satsuma Pharmaceuticals Inc (STSA) Stock Will Go?

Wall Street is positive on Satsuma Pharmaceuticals Inc (STSA). On average, analysts give STSA a Buy rating. The average price target is $2, which means analysts expect the stock to add by 92.31% over the next twelve months. That average ranking earns STSA an Analyst Rating of 21, which is better than 21% of stocks based on data compiled by InvestorsObserver.

Wall Street analysts are rating STSA a Buy today. Find out what this means to you and get the rest of the rankings on STSA!

See Full STSA Report

Why are Analyst Ratings Important?

A company's financial statements are a significant factor weighted by experts when analyzing a company's health. Beyond just the numbers, analysts follow specific industries closely and are able to gain a detailed understanding of how a storm in one part of the world can shutdown supply chains leading to a change in consumption across the globe. This knowledge allows investors to respond to potential changes in the market before they are revealed in a quarterly annoucement. InvestorsObserver averages the ratings across all these analysts and percentile ranks those averages. This allows you to compare stocks in greater detail than the usual five-tiered system used amongst the majority of investors.

What's Happening With Satsuma Pharmaceuticals Inc Stock Today?

Satsuma Pharmaceuticals Inc (STSA) stock is up 0.97% while the S&P 500 is lower by -0.67% as of 10:18 AM on Tuesday, Apr 25. STSA has risen $0.01 from the previous closing price of $1.03 on volume of 68,119 shares. Over the past year the S&P 500 is lower by -4.35% while STSA is lower by -75.47%. STSA lost -$2.19 per share the over the last 12 months. Click Here to get the full Stock Report for Satsuma Pharmaceuticals Inc stock.